サイズを選択してください
この商品について
Quality Level
description
Cell line type: Neural Lineage Cells, Induced Pluripotent Stem Cells , Neural Stem Cells
technique(s)
cell culture | mammalian: suitable, cell culture | stem cell: suitable, cell differentiation: suitable
General description
These hiPSC-derived NPCs proliferate as an adherent cell monolayer with greater than 80% expression of the appropriate neural stem cell markers, including Nestin and Sox-2. Cells are provided at passage 3 and can be expanded for a further three to five passages with ENStem-A Neural Expansion Medium (Cat. No. SCM004). Human NPCs can be further differentiated to terminal neurons by the use of the Human ES/iPS Neuronal Differentiation Medium (Cat. No. SCM111) or ENStem-A Neuronal Differentiation Medium (Cat. No. SCM017). Differentiation leads to greater than 80-90% of the cells expressing mostly neuronal markers, bIII-tubulin and MAP2.
Human iPSC-derived NPCs can be used for a variety of research applications including studies of neurotoxicity, co-culture applications and screening for molecules that induce or inhibit preferential differentiation to mature neurons.
Preparation Note
Other Notes
Disclaimer
保管分類
12 - Non Combustible Liquids
wgk
WGK 2
適用法令
試験研究用途を考慮した関連法令を主に挙げております。化学物質以外については、一部の情報のみ提供しています。 製品を安全かつ合法的に使用することは、使用者の義務です。最新情報により修正される場合があります。WEBの反映には時間を要することがあるため、適宜SDSをご参照ください。
Poisonous substance
pdsc
SCC035:
jan
試験成績書(COA)
製品のロット番号・バッチ番号を入力して、試験成績書(COA) を検索できます。ロット番号・バッチ番号は、製品ラベルに「Lot」または「Batch」に続いて記載されています。
関連コンテンツ
Dual SMAD inhibition is a well-established method to derive neural progenitor cells from both human ES and iPS cells. This protocol uses two SMAD inhibitors, Noggin and SB431542, to drive the rapid differentiation of ES/iPS cells into a highly enriched population of NPCs. Noggin acts as a BMP inhibitor and SB431542 inhibits the Lefty/Activin/TGFβ pathways by blocking the phosphorylation of ALK4, ALK5, and ALK7 receptors. In an effort to make a more defined and optimized neuronal differentiation protocol, Li and colleagues modified the original protocol to establish a completely small molecule-based differentiation method, which relies on three small molecules to inhibit GSK-3β (CHIR99021), TGFβ (SB431542), and Notch (compound E) signaling pathways, along with human LIF3. This new small molecule-based neural differentiation protocol increased neural differentiation kinetics and allowed the derivation of truly multipotent neural stem cells that respond to regional patterning cues specifying forebrain, midbrain, and hindbrain neural and glial subtypes.
グローバルトレードアイテム番号
| カタログ番号 | GTIN |
|---|---|
| SCC035 | 04053252910401 |